Royal Bank of Canada’s Tema Oncology ETF CANC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$324K Buy
+7,849
New +$297K ﹤0.01% 4674
2024
Q4
– Sell
-121
Closed -$3K – 6911
2024
Q3
$3K Buy
+121
New +$3.48K ﹤0.01% 6583

Other funds holding CANC

Royal Bank of Canada's CANC Position: Q2 2026 in Review

Royal Bank of Canada opened a new position in Tema Oncology ETF (CANC) in Q2 2026: 7,849 shares worth $324K. The stake represents ﹤0.01% of the portfolio and ranks #4674 among its holdings. This is a return to the name: Royal Bank of Canada previously reported a position in CANC as recently as Q3 2024.

Royal Bank of Canada first reported a position in CANC in Q3 2024 and has held it in 2 quarters since. 14 funds tracked by Wall St. Rank hold CANC as of Q2 2026.

  • Royal Bank of Canada held 7,849 shares of Tema Oncology ETF worth $324K as of Q2 2026.
  • Tema Oncology ETF was a new Royal Bank of Canada position in Q2 2026.
  • Tema Oncology ETF made up ﹤0.01% of Royal Bank of Canada's portfolio in Q2 2026, its #4674 holding.
  • Royal Bank of Canada first reported a position in Tema Oncology ETF in Q3 2024 and has held it in 2 quarters since.
  • 14 funds tracked by Wall St. Rank held Tema Oncology ETF as of Q2 2026.

Based on Royal Bank of Canada's 13F filing for Q2 2026, filed 14 Aug 2026.